With roots dating to 1997, Shenzhen Haorui Pharmatech supplies a broad portfolio of active pharmaceutical ingredients spanning anti-infectives (levofloxacin, linezolid, tigecycline, anidulafungin, rifaximin), immunosuppressants and specialty drugs (tacrolimus, rocuronium bromide, relugolix, sitagliptin), and emerging therapeutics such as orforglipron, alongside veterinary APIs and nutritional/health-product raw materials. The company offers CMO and CDMO contract manufacturing and distributes to customers across North America, Europe, Asia, the Middle East, and Africa.
댓글이 없습니다.
평가 & 댓글 남기기